Sunday, June 4, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Medicine & Health

USC Health System Board appoints Paul B. Rothman, MD, as board member

May 23, 2023
in Medicine & Health
0
Share on FacebookShare on Twitter

LOS ANGELES — Paul B. Rothman, MD, has been appointed as a member of the USC Health System Board, which provides strategic oversight and governance over Keck Medicine of USC and university clinical services. 

Paul B. Rothman, MD, former CEO of Johns Hopkins Medicine, joins USC Health System Board

Credit: Photo courtesy of Johns Hopkins University School of Medicine

LOS ANGELES — Paul B. Rothman, MD, has been appointed as a member of the USC Health System Board, which provides strategic oversight and governance over Keck Medicine of USC and university clinical services. 

Rothman, former CEO of Johns Hopkins Medicine and retired dean of medical faculty for the Johns Hopkins University School of Medicine, brings his leadership acumen as well as clinical and scientific expertise in rheumatology and molecular immunology to this advisory role. 

“Paul Rothman is a most-highly respected and accomplished physician-leader with a strategic vision, and we are honored to have him join the USC Health System Board,” said Steven D. Shapiro, MD, senior vice president for health affairs, University of Southern California. “His insight and experience leading one of the most preeminent academic health systems will be invaluable as we usher our innovative academic medical center into the future.”  

In addition to his leadership experience, Rothman also is a member of the National Academy of Medicine, the American Academy of Arts and Sciences, the American Association for the Advancement of Science and the American Society for Clinical Investigation. He is a member of the Association of American Physicians and served as president in 2014. 

“I look forward to working alongside the esteemed professionals of the USC Health System Board as we advance the mission of the health system to deliver cutting-edge care and groundbreaking research to Los Angeles and beyond,” said Rothman.  

Rothman also previously served as dean of the College of Medicine at the University of Iowa and as head of medicine at the University of Iowa. Prior to this, he served as vice chairman for research and founding director of the Division of Pulmonary, Allergy and Critical Care Medicine at Columbia University College of Physicians and Surgeons, where he joined the faculty in 1990. 

Rothman earned his Bachelor of Science in biology from the Massachusetts Institute of Technology and earned his medical degree from Yale University. He completed both an internal medicine residency and a rheumatology fellowship at New York-Presbyterian/Columbia University Irving Medical Center, as well as a postdoctoral biochemistry fellowship at Columbia University College of Physicians and Surgeons. 

###   

For more information about Keck Medicine of USC, please visit news.KeckMedicine.org.   



Tags: appointsboardhealthmemberPaulRothmansystemUSC
Share25Tweet16Share4ShareSendShare
  • Nearly 70% of private label avocado oil rancid or mixed with other oils

    65 shares
    Share 26 Tweet 16
  • Null results research now published by major behavioral medicine journal

    782 shares
    Share 313 Tweet 196
  • UC Davis C-STEM trains Redlands teachers on bringing computer science into math

    65 shares
    Share 26 Tweet 16
  • Mozart may reduce seizure frequency in people with epilepsy

    67 shares
    Share 27 Tweet 17
  • The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

    64 shares
    Share 26 Tweet 16
  • Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

    64 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Null results research now published by major behavioral medicine journal

Why expensive wine appears to taste better

Element creation in the lab deepens understanding of surface explosions on neutron stars

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 206 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In